Halo Therapeutics Receives $500,000 MDA Award to Develop Drug for Duchenne Muscular Dystrophy

Disease: 
Link: 
Time Stamp: 
0
Thumbnail: 
http://mda.org/sites/default/files/HALO_LOGO_FIN.png